• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大麻与多发性硬化症中的认知功能:性别角色

Cannabis and cognitive functioning in multiple sclerosis: The role of gender.

作者信息

Patel Viral P, Feinstein Anthony

机构信息

Department of Psychiatry, Sunnybrook Health Sciences Center, Canada.

出版信息

Mult Scler J Exp Transl Clin. 2017 Jun 8;3(2):2055217317713027. doi: 10.1177/2055217317713027. eCollection 2017 Apr-Jun.

DOI:10.1177/2055217317713027
PMID:28634543
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5468765/
Abstract

BACKGROUND

Cognitive function in people with multiple sclerosis (PwMS) is associated with gender differences and the use of smoked/ingested cannabis.

OBJECTIVE

The objective of this report is to explore a possible gender-cannabis interaction associated with cognitive dysfunction in PwMS.

METHODS

A retrospective analysis was undertaken of cognitive data collected from 140 PwMS. A general linear model was conducted to determine gender and cannabis effects on processing speed (SDMT), verbal (CVLT-II) and visual (BVMT-R) memory, and executive functions (D-KEFS), while controlling for age and years of education.

RESULTS

Cannabis was smoked at least once a month by 33 (23.6%) participants. Cannabis users were more impaired on the SDMT ( = 0.044). Men, who comprised 30.7% of the entire sample and 42.2% of cannabis users, were more impaired on the CVLT-II (total learning,  = 0.001; delayed recall,  = 0.004). A cannabis-gender interaction was found with the CVLT-II delayed recall ( = 0.049) and BVMT-R total learning ( = 0.014), where male cannabis users performed more poorly than female.

CONCLUSION

Males with MS may be particularly vulnerable to the cognitive side effects of smoked cannabis use.

摘要

背景

多发性硬化症患者(PwMS)的认知功能与性别差异以及吸食/摄入大麻有关。

目的

本报告的目的是探讨PwMS中与认知功能障碍相关的性别-大麻相互作用。

方法

对从140名PwMS收集的认知数据进行回顾性分析。进行一般线性模型以确定性别和大麻对处理速度(SDMT)、言语(CVLT-II)和视觉(BVMT-R)记忆以及执行功能(D-KEFS)的影响,同时控制年龄和受教育年限。

结果

33名(23.6%)参与者每月至少吸食一次大麻。大麻使用者在SDMT上受损更严重(=0.044)。男性占整个样本的30.7%,占大麻使用者的42.2%,在CVLT-II上受损更严重(总学习,=0.001;延迟回忆,=0.004)。在CVLT-II延迟回忆(=0.049)和BVMT-R总学习(=0.014)方面发现了大麻-性别相互作用,男性大麻使用者的表现比女性更差。

结论

患有多发性硬化症的男性可能特别容易受到吸食大麻的认知副作用的影响。

相似文献

1
Cannabis and cognitive functioning in multiple sclerosis: The role of gender.大麻与多发性硬化症中的认知功能:性别角色
Mult Scler J Exp Transl Clin. 2017 Jun 8;3(2):2055217317713027. doi: 10.1177/2055217317713027. eCollection 2017 Apr-Jun.
2
Brief international cognitive assessment for multiple sclerosis (BICAMS): A danish validation study of sensitivity in early stages of MS.简要国际认知评估多发性硬化症(BICAMS):丹麦在多发性硬化症早期阶段的敏感性验证研究。
Mult Scler Relat Disord. 2020 Jan;37:101458. doi: 10.1016/j.msard.2019.101458. Epub 2019 Oct 18.
3
Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): Canadian contribution to the international validation project.多发性硬化症简短国际认知评估(BICAMS):加拿大对国际验证项目的贡献。
J Neurol Sci. 2016 Mar 15;362:147-52. doi: 10.1016/j.jns.2016.01.040. Epub 2016 Jan 21.
4
The relationship between processing speed and verbal and non-verbal new learning and memory in progressive multiple sclerosis.进展性多发性硬化症中处理速度与言语和非言语新学习和记忆的关系。
Mult Scler. 2022 Oct;28(11):1783-1792. doi: 10.1177/13524585221088190. Epub 2022 May 9.
5
Sleep-disordered breathing and neurocognitive function in multiple sclerosis: Differential associations across cognitive domains.多发性硬化症中的睡眠障碍性呼吸和神经认知功能:认知领域的不同关联。
Mult Scler. 2023 Jun;29(7):832-845. doi: 10.1177/13524585231169465. Epub 2023 May 17.
6
A preliminary validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) tool in an Irish population with multiple sclerosis (MS).多发性硬化症简短国际认知评估工具(BICAMS)在爱尔兰多发性硬化症(MS)患者群体中的初步验证。
Mult Scler Relat Disord. 2015 Nov;4(6):521-5. doi: 10.1016/j.msard.2015.07.012. Epub 2015 Aug 7.
7
The Brief International Cognitive Assessment in Multiple Sclerosis (BICAMS): results from the German validation study.多发性硬化症的简短国际认知评估(BICAMS):德国验证研究结果。
J Neurol. 2018 Nov;265(11):2587-2593. doi: 10.1007/s00415-018-9034-1. Epub 2018 Aug 31.
8
A new assessment tool for patients with multiple sclerosis from Spanish-speaking countries: validation of the Brief International Cognitive Assessment for MS (BICAMS) in Argentina.一种针对来自西班牙语国家的多发性硬化症患者的新评估工具:简易国际多发性硬化症认知评估量表(BICAMS)在阿根廷的验证。
Clin Neuropsychol. 2016 Oct;30(7):1023-31. doi: 10.1080/13854046.2016.1184317. Epub 2016 May 12.
9
Impaired awareness: Why people with multiple sclerosis continue using cannabis despite evidence to the contrary.意识受损:为什么多发性硬化症患者尽管有相反的证据仍继续使用大麻。
Brain Behav. 2021 Aug;11(8):e2220. doi: 10.1002/brb3.2220. Epub 2021 Jun 4.
10
Cannabis use and cognitive function: 8-year trajectory in a young adult cohort.大麻使用与认知功能:年轻成人队列中的 8 年轨迹。
Addiction. 2011 Dec;106(12):2195-203. doi: 10.1111/j.1360-0443.2011.03574.x. Epub 2011 Oct 17.

引用本文的文献

1
Cannabis and Cognitive Function in Multiple Sclerosis: Findings From a Large Consecutive Clinical Sample.大麻与多发性硬化症的认知功能:来自大型连续临床样本的研究结果
Eur J Neurol. 2025 Jul;32(7):e70142. doi: 10.1111/ene.70142.
2
The unmet need for cannabis use disorder treatment in multiple sclerosis: Insights from a nationwide pilot study.多发性硬化症中对大麻使用障碍治疗的未满足需求:一项全国性试点研究的见解。
Mult Scler Relat Disord. 2025 Jun;98:106443. doi: 10.1016/j.msard.2025.106443. Epub 2025 Apr 14.
3
A Critical Review of the Role of the Cannabinoid Compounds Δ-Tetrahydrocannabinol (Δ-THC) and Cannabidiol (CBD) and their Combination in Multiple Sclerosis Treatment.大麻素化合物 Δ-四氢大麻酚(Δ-THC)和大麻二酚(CBD)及其联合在多发性硬化症治疗中的作用的批判性评价。
Molecules. 2020 Oct 25;25(21):4930. doi: 10.3390/molecules25214930.
4
Cannabis-based product use in a multiple sclerosis cohort.基于大麻的产品在多发性硬化症队列中的使用情况。
Mult Scler J Exp Transl Clin. 2019 Sep 25;5(3):2055217319869360. doi: 10.1177/2055217319869360. eCollection 2019 Jul-Sep.
5
The effects of cannabinoid 1 receptor compounds on memory: a meta-analysis and systematic review across species.大麻素 1 受体化合物对记忆的影响:跨物种的荟萃分析和系统评价。
Psychopharmacology (Berl). 2019 Nov;236(11):3257-3270. doi: 10.1007/s00213-019-05283-3. Epub 2019 Jun 5.
6
Recommendations for cognitive screening and management in multiple sclerosis care.多发性硬化症护理中的认知筛查和管理建议。
Mult Scler. 2018 Nov;24(13):1665-1680. doi: 10.1177/1352458518803785. Epub 2018 Oct 10.

本文引用的文献

1
Attitudes to cannabis and patterns of use among Canadians with multiple sclerosis.多发性硬化症患者对大麻的态度和使用模式。
Mult Scler Relat Disord. 2016 Nov;10:123-126. doi: 10.1016/j.msard.2016.09.008. Epub 2016 Sep 28.
2
Long-term hippocampal glutamate synapse and astrocyte dysfunctions underlying the altered phenotype induced by adolescent THC treatment in male rats.长期的海马谷氨酸突触和星形胶质细胞功能障碍是青少年 THC 处理诱导雄性大鼠表型改变的基础。
Pharmacol Res. 2016 Sep;111:459-470. doi: 10.1016/j.phrs.2016.07.008. Epub 2016 Jul 12.
3
Distraction adds to the cognitive burden in multiple sclerosis.注意力分散会加重多发性硬化症患者的认知负担。
Mult Scler. 2017 Jan;23(1):106-113. doi: 10.1177/1352458516641208. Epub 2016 Jul 11.
4
Effects of cannabis on cognition in patients with MS: a psychometric and MRI study.大麻对多发性硬化症患者认知功能的影响:一项心理测量和核磁共振成像研究。
Neurology. 2014 May 27;82(21):1879-87. doi: 10.1212/WNL.0000000000000446. Epub 2014 Apr 30.
5
Gender-related differences in functional connectivity in multiple sclerosis.多发性硬化症中功能连接的性别差异。
Mult Scler. 2012 Feb;18(2):164-73. doi: 10.1177/1352458511422245. Epub 2011 Sep 9.
6
Effects of cannabis on cognitive function in patients with multiple sclerosis.大麻对多发性硬化症患者认知功能的影响。
Neurology. 2011 Mar 29;76(13):1153-60. doi: 10.1212/WNL.0b013e318212ab0c.
7
Acute and non-acute effects of cannabis on brain functioning and neuropsychological performance.大麻对大脑功能和神经心理表现的急性和非急性影响。
Neuropsychol Rev. 2007 Sep;17(3):347-61. doi: 10.1007/s11065-007-9036-8.
8
Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis.临床和遗传变量对多发性硬化症认知障碍的性别相关影响。
J Neurol. 2004 Oct;251(10):1208-14. doi: 10.1007/s00415-004-0508-y.
9
The hospital anxiety and depression scale.医院焦虑抑郁量表。
Acta Psychiatr Scand. 1983 Jun;67(6):361-70. doi: 10.1111/j.1600-0447.1983.tb09716.x.